======= ZBTB4 ======= == Gene Information == * **Official Symbol**: ZBTB4 * **Official Name**: zinc finger and BTB domain containing 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57659|57659]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P1Z0|Q9P1Z0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZBTB4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZBTB4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612308|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor with bimodal DNA-binding specificity. Represses transcription in a methyl-CpG-dependent manner. Binds with a higher affinity to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' but can also bind to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Can also bind specifically to a single methyl-CpG pair and can bind hemimethylated DNA but with a lower affinity compared to methylated DNA (PubMed:16354688). Plays a role in postnatal myogenesis, may be involved in the regulation of satellite cells self-renewal (By similarity). {ECO:0000250|UniProtKB:Q5F293, ECO:0000269|PubMed:16354688}. |BTB| |methyl-CpNpG binding| |methyl-CpG binding| |chromosome| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |nuclear body| |RNA polymerase II regulatory region sequence-specific DNA binding| |sequence-specific DNA binding| |protein kinase binding| |DNA-binding transcription factor activity| |cellular response to DNA damage stimulus| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular response to stress| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp326|CCT251545 20μM R07 exp326]]|-1.96| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6269 * **Expression level (log2 read counts)**: 4.37 {{:chemogenomics:nalm6 dist.png?nolink |}}